Production (Stage)
scPharmaceuticals Inc.
SCPH
$3.55
-$0.03-0.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 57.90M | 76.68M | 92.63M | 38.88M | 58.98M |
| Total Receivables | 13.85M | 11.72M | 9.22M | 6.12M | 5.77M |
| Inventory | 14.14M | 13.90M | 18.11M | 15.31M | 9.57M |
| Prepaid Expenses | 3.46M | 3.55M | 3.37M | 2.33M | 2.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 89.35M | 105.85M | 123.33M | 62.63M | 76.53M |
|
|
|||||
| Total Current Assets | 89.35M | 105.85M | 123.33M | 62.63M | 76.53M |
| Net Property, Plant & Equipment | 1.29M | 1.33M | 1.38M | 1.36M | 1.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 322.00K | 341.00K | 359.00K | 1.47M | 522.00K |
| Total Assets | 90.96M | 107.52M | 125.07M | 65.46M | 78.45M |
|
|
|||||
| Total Accounts Payable | 4.99M | 3.88M | 5.00M | 5.29M | 2.71M |
| Total Accrued Expenses | 9.84M | 9.73M | 9.87M | 7.40M | 9.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 254.00K | 239.00K | 231.00K | 190.00K | 184.00K |
| Total Finance Division Other Current Liabilities | 1.23M | 1.02M | 162.00K | 47.00K | 222.00K |
| Total Other Current Liabilities | 1.23M | 1.02M | 162.00K | 47.00K | 222.00K |
| Total Current Liabilities | 16.31M | 14.88M | 15.26M | 12.93M | 12.32M |
|
|
|||||
| Total Current Liabilities | 16.31M | 14.88M | 15.26M | 12.93M | 12.32M |
| Long-Term Debt | 51.05M | 51.35M | 51.10M | 39.99M | 39.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.05M | 1.10M | 1.17M | 1.18M | 1.23M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.68M | 26.87M | 26.83M | 2.10M | 952.00K |
| Total Liabilities | 96.09M | 94.20M | 94.36M | 56.21M | 53.89M |
|
|
|||||
| Common Stock & APIC | 381.11M | 379.81M | 378.36M | 321.79M | 320.02M |
| Retained Earnings | -386.24M | -366.49M | -347.65M | -312.54M | -295.45M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -5.13M | 13.32M | 30.71M | 9.25M | 24.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.13M | 13.32M | 30.71M | 9.25M | 24.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.13M | 13.32M | 30.71M | 9.25M | 24.57M |
|
|
|||||